Evidence map›Paper›PMID 30784076›Full record

ArticleJournal of cellular physiology2019

SNX9 determines the surface levels of integrin β1 in vascular endothelial cells: Implication in poor prognosis of human colorectal cancers overexpressing SNX9.

Kazufumi Tanigawa, Masashi Maekawa, Takeshi Kiyoi, Jun Nakayama, Riko Kitazawa, Sohei Kitazawa, Kentaro Semba, Tomohiko Taguchi, Satoshi Akita, Motohira Yoshida and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cellular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. RAB40C regulates SNX9 stabilityCentral-European journal of immunology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. PI(3,4)PProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Kazufumi TanigawaDepartment of Gastrointestinal Surgery and Surgical Oncology, Ehime University Graduate School of Medicine.
Masashi MaekawaDepartment of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Ehime, Japan.ORCID 0000-0002-9574-1906
Takeshi KiyoiDivision of Analytical Bio-medicine, Advanced Research Support Center, Ehime University.
Jun NakayamaDepartment of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University.
Riko KitazawaDepartment of Molecular Pathology, Ehime University Graduate School of Medicine.
Sohei KitazawaDepartment of Molecular Pathology, Ehime University Graduate School of Medicine.
Kentaro SembaDepartment of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University.
Tomohiko TaguchiDepartment of Integrative Life Sciences, Graduate School of Life Sciences, Tohoku University.
Satoshi AkitaDepartment of Gastrointestinal Surgery and Surgical Oncology, Ehime University Graduate School of Medicine.
Motohira YoshidaDepartment of Gastrointestinal Surgery and Surgical Oncology, Ehime University Graduate School of Medicine.
Kei IshimaruDepartment of Gastrointestinal Surgery and Surgical Oncology, Ehime University Graduate School of Medicine.
Yuji WatanabeDepartment of Gastrointestinal Surgery and Surgical Oncology, Ehime University Graduate School of Medicine.
Shigeki HigashiyamaDepartment of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Ehime, Japan.
Ehime University · JPTumaini University · TZWaseda University · JPEhime University Hospital · JPTohoku University · JPZero to Three · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis, the formation of new blood vessels, is involved in a variety of diseases including the tumor growth. In response to various angiogenic stimulations, a number of proteins on the surface of vascular endothelial cells are activated to coordinate cell proliferation, migration, and spreading processes to form new blood vessels. Plasma membrane localization of these angiogenic proteins, which include vascular endothelial growth factor receptors and integrins, are warranted by intracellular membrane trafficking. Here, by using a siRNA library, we screened for the sorting nexin family that regulates intracellular trafficking and identified sorting nexin 9 (SNX9) as a novel angiogenic factor in human umbilical vein endothelial cells (HUVECs). SNX9 was essential for cell spreading on the Matrigel, and tube formation that mimics in vivo angiogenesis in HUVECs. SNX9 depletion significantly delayed the recycling of integrin β1, an essential adhesion molecule for angiogenesis, and reduced the surface levels of integrin β1 in HUVECs. Clinically, we showed that SNX9 protein was highly expressed in tumor endothelial cells of human colorectal cancer tissues. High-level expression of SNX9 messenger RNA significantly correlated with poor prognosis of the patients with colorectal cancer. These results suggest that SNX9 is an angiogenic factor and provide a novel target for the development of new antiangiogenic drugs.

Indexed as

Angiogenesis Inducing AgentsCell MembraneCell MovementCell ProliferationColorectal NeoplasmsHumansHuman Umbilical Vein Endothelial CellsIntegrin beta1IntegrinsNeovascularization, PathologicProtein TransportSorting NexinsAngiogenesis Inducing AgentsIntegrin beta1IntegrinsItgb1 protein, humanSNX9 protein, humanSorting Nexinsangiogenesiscolorectal cancerendothelial cellsintegrin β1sorting nexin 9

Identifiers

PMID30784076
PMCPMC6617759
OpenAlexW2915217905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.